Pharmaceutical

Booster Therapeutics to develop proteasome activator medicines

Booster Therapeutics has announced its inception to develop a new class of proteasome activator medicines for neurodegenerative diseases.

Oct 12, 2024 - 04:00
Booster Therapeutics to develop proteasome activator medicines
Booster Therapeutics has announced its inception to develop a new class of proteasome activator medicines for neurodegenerative diseases.
Read the original article

Tags:

Previous Article

Activist investor Starboard cries foul play in exec U-turn at Pfizer

Next Article

KeyBioscience and Eli Lilly extend partnership for obesity treatments

What's Your Reaction?

like

dislike

love

funny

angry

sad

wow

Related Posts

Can pharma overcome generative AI’s bias problem?

Can pharma overcome generative AI’s bias problem?

Apr 3, 2024

Pan Cancer T raises funds through seed extension round

Pan Cancer T raises funds through seed extension round

Jul 14, 2024

In North Carolina, a radical experiment targets social determinants of health with fresh produce and safe housing

In North Carolina, a radical experiment targets social ...

Sep 22, 2023